JPMorgan Chase & Co. Lowers H.B. Fuller (NYSE:FUL) Price Target to $50.00

H.B. Fuller (NYSE:FUL - Get Free Report) had its price objective reduced by analysts at JPMorgan Chase & Co. from $60.00 to $50.00 in a report issued on Friday,Benzinga reports. The firm presently has an "underweight" rating on the specialty chemicals company's stock. JPMorgan Chase & Co.'s target price indicates a potential downside of 10.97% from the stock's current price.

Other equities research analysts also recently issued reports about the company. Vertical Research downgraded H.B. Fuller from a "buy" rating to a "hold" rating in a report on Monday, January 6th. Deutsche Bank Aktiengesellschaft lowered their target price on shares of H.B. Fuller from $75.00 to $72.00 and set a "buy" rating on the stock in a report on Wednesday, January 22nd. Citigroup dropped their price target on shares of H.B. Fuller from $78.00 to $68.00 and set a "neutral" rating on the stock in a research note on Friday, January 3rd. Finally, Seaport Res Ptn downgraded shares of H.B. Fuller from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, March 5th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $70.00.

H.B. Fuller Stock Performance

NYSE FUL traded up $0.04 during trading on Friday, reaching $56.16. The company's stock had a trading volume of 147,608 shares, compared to its average volume of 357,158. The business's fifty day moving average price is $58.19 and its 200-day moving average price is $68.44. H.B. Fuller has a twelve month low of $52.59 and a twelve month high of $87.67. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.16 and a current ratio of 1.81. The firm has a market cap of $3.04 billion, a price-to-earnings ratio of 24.31, a P/E/G ratio of 1.13 and a beta of 1.41.

H.B. Fuller (NYSE:FUL - Get Free Report) last issued its quarterly earnings results on Wednesday, March 26th. The specialty chemicals company reported $0.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.49 by $0.05. H.B. Fuller had a return on equity of 12.01% and a net margin of 3.65%. The firm had revenue of $788.66 million for the quarter, compared to analysts' expectations of $769.55 million. During the same quarter in the previous year, the firm posted $0.67 EPS. The firm's revenue for the quarter was down 2.7% on a year-over-year basis. As a group, analysts anticipate that H.B. Fuller will post 4.07 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Geode Capital Management LLC boosted its stake in shares of H.B. Fuller by 1.5% during the 3rd quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company's stock worth $99,939,000 after acquiring an additional 18,734 shares in the last quarter. Lord Abbett & CO. LLC boosted its position in H.B. Fuller by 79.8% during the third quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company's stock worth $57,952,000 after purchasing an additional 324,056 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in H.B. Fuller by 17.2% in the fourth quarter. Bank of New York Mellon Corp now owns 554,947 shares of the specialty chemicals company's stock valued at $37,448,000 after purchasing an additional 81,558 shares during the last quarter. Kennedy Capital Management LLC grew its holdings in H.B. Fuller by 13.4% in the fourth quarter. Kennedy Capital Management LLC now owns 127,896 shares of the specialty chemicals company's stock valued at $8,630,000 after purchasing an additional 15,100 shares during the last quarter. Finally, MetLife Investment Management LLC increased its position in shares of H.B. Fuller by 4.7% in the fourth quarter. MetLife Investment Management LLC now owns 33,058 shares of the specialty chemicals company's stock valued at $2,231,000 after buying an additional 1,472 shares in the last quarter. 95.93% of the stock is owned by hedge funds and other institutional investors.

H.B. Fuller Company Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.